Showing 13–20 of 20 results

Tagrisso 80 mg Alternative – Ositag (Osimertinib) 80 mg Tablet | Beacon Pharmaceuticals

Ositag 80 mg (Osimertinib) Tablet by Beacon Pharmaceuticals. Reference brand: Tagrisso. EGFR inhibitor; used in selected EGFR-mutated lung cancer. Prescription medicine. Brand comparison does not establish interchangeability.

Tarceva 100 mg Alternative – Erlocent (Erlotinib) 100 mg Tablet | Incepta Pharmaceuticals

Erlocent 100 mg (Erlotinib) Tablet is listed in the supplied Lucent price catalogue attributed to Incepta Pharmaceuticals Ltd. Reference brand: Tarceva (Roche / Genentech).

Pack: 10 tablets. Prescription medicine. Verify the exact manufacturer label and regulatory status; reference-brand comparison does not establish interchangeability.

Tarceva 100 mg Alternative – Erlonix (Erlotinib) 100 mg Tablet | Beacon Pharmaceuticals

Erlonix 100 mg (Erlotinib) Tablet by Beacon Pharmaceuticals. Reference brand: Tarceva. EGFR inhibitor; used in selected EGFR-mutated non-small cell lung cancer. Prescription medicine. Brand comparison does not establish interchangeability.

Tarceva 150 mg Alternative – Erlocent (Erlotinib) 150 mg Tablet | Incepta Pharmaceuticals

Erlocent 150 mg (Erlotinib) Tablet is listed in the supplied Lucent price catalogue attributed to Incepta Pharmaceuticals Ltd. Reference brand: Tarceva (Roche / Genentech).

Pack: 10 tablets. Prescription medicine. Verify the exact manufacturer label and regulatory status; reference-brand comparison does not establish interchangeability.

Vizimpro 45 mg Alternative – Dacocent (Dacomitinib) 45 mg Tablet | Incepta Pharmaceuticals

Dacocent 45 mg (Dacomitinib) by Incepta Pharmaceuticals. EGFR inhibitor for selected EGFR-mutated NSCLC. Reference brand: Vizimpro (Pfizer). Pack: 10 tablets. Prescription only; equivalence not established.

Xalkori 250 mg Alternative – Alkixen (Crizotinib) 250 mg Capsule | Everest Pharmaceuticals

Alkixen 250 mg (Crizotinib) by Everest Pharmaceuticals Ltd. is listed as an alternative-brand option for customers researching Xalkori (Pfizer). It belongs to the ALK/ROS1 kinase inhibitor class and is used in selected ALK-positive or ROS1-positive non-small cell lung cancer.

Active ingredient: Crizotinib
Strength: 250 mg
Form: Capsule
Manufacturer: Everest Pharmaceuticals Ltd., Bangladesh

Prescription required. Shared active ingredients do not establish bioequivalence or automatic interchangeability.

Xalkori 250 mg Alternative – Alkriz (Crizotinib) 250 mg Tablet | Beacon Pharmaceuticals

Alkriz 250 mg (Crizotinib) Tablet by Beacon Pharmaceuticals. Reference brand: Xalkori. ALK/ROS1 kinase inhibitor; used in molecularly selected non-small cell lung cancer. Prescription medicine. Brand comparison does not establish interchangeability.

Xalkori 250 mg Alternative – Crizocent (Crizotinib) 250 mg Capsule | Incepta Pharmaceuticals

Crizocent 250 mg (Crizotinib) Capsule is listed in the supplied Lucent price catalogue attributed to Incepta Pharmaceuticals Ltd. Reference brand: Xalkori (Pfizer).

Pack: 12 capsules. Prescription medicine. Verify the exact manufacturer label and regulatory status; reference-brand comparison does not establish interchangeability.